These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34986363)

  • 1. Anti-NXP2 Positive Dermatomyositis Causing Rhabdomyolysis: An Atypical Presentation.
    Shah V; Yaffe B; Gutman D
    Am J Med Sci; 2022 May; 363(5):e49-e50. PubMed ID: 34986363
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of dermatomyositis with rhabdomyolysis, rescued by intravenous immunoglobulin.
    Mizoguchi F; Takada K; Ishikawa K; Mizusawa H; Kohsaka H; Miyasaka N
    Mod Rheumatol; 2015 Jul; 25(4):646-8. PubMed ID: 24252047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute onset of dermatomyositis presenting in pregnancy with rhabdomyolysis and fetal loss.
    Kofteridis DP; Malliotakis PI; Sotsiou F; Vardakis NK; Vamvakas LN; Emmanouel DS
    Scand J Rheumatol; 1999; 28(3):192-4. PubMed ID: 10380845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NXP2-positive dermatomyositis complicated with refractory skin edema: Successful treatment with tocilizumab.
    Lu Z; Chen Y; Xue J; Liu L
    Dermatol Ther; 2021 Jan; 34(1):e14712. PubMed ID: 33368804
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody.
    Yan TT; Zhang X; Yang HH; Sun WJ; Liu L; Du Y; Xue J
    Clin Rheumatol; 2021 Sep; 40(9):3695-3702. PubMed ID: 33712891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.
    Tansley SL; Betteridge ZE; Shaddick G; Gunawardena H; Arnold K; Wedderburn LR; McHugh NJ;
    Rheumatology (Oxford); 2014 Dec; 53(12):2204-8. PubMed ID: 24987158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the Interferon score in the management of an anti-NXP2 dermatomyositis patient with calcinosis successfully treated with tofacitinib.
    Robert M; Gallay L; Garnier L; Pescarmona R; Hot A
    Joint Bone Spine; 2023 Jul; 90(4):105532. PubMed ID: 36706944
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of refractory anti-NXP2 and anti-TIF1γ dermatomyositis with tofacitinib.
    Navarro-Navarro I; Jiménez-Gallo D; Rodríguez-Mateos ME; Rodríguez-Hernández C; Linares-Barrios M
    J Dtsch Dermatol Ges; 2021 Mar; 19(3):443-447. PubMed ID: 32909360
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy.
    Okada Y; Izumi R; Hosaka T; Watanabe S; Shijo T; Hatchome N; Konishi R; Ichimura Y; Okiyama N; Suzuki N; Misu T; Aoki M
    Rheumatology (Oxford); 2022 Apr; 61(4):e90-e92. PubMed ID: 34850853
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary pulmonary diffuse large B-cell lymphoma with anti-NXP2-positive dermatomyositis: a case report.
    Yao F; Deng L; Liao Z; Wen Z
    Clin Exp Rheumatol; 2024 Feb; 42(2):454-455. PubMed ID: 37650343
    [No Abstract]   [Full Text] [Related]  

  • 12. Universalis Calcinosis in Adult Dermatomyositis: An "Anti-NXP2 Syndrome".
    Fodil D; Meyer A; Salah SS; Sibilia J; Attal N; Tafiani-Lefkir S
    J Clin Rheumatol; 2016 Oct; 22(7):387-9. PubMed ID: 27660942
    [No Abstract]   [Full Text] [Related]  

  • 13. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retrospective analysis of anti-TIF1gamma, anti-NXP2 and anti-SAE1/2 antibodies carriers at Bordeaux university hospital from November 2014 to February 2017].
    Victor J; Zanardo L; Héron-Mermin D; Poursac N; Solé G; Bordes C; Duffau P
    Rev Med Interne; 2019 Feb; 40(2):70-81. PubMed ID: 30527961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis.
    Aouizerate J; De Antonio M; Bader-Meunier B; Barnerias C; Bodemer C; Isapof A; Quartier P; Melki I; Charuel JL; Bassez G; Desguerre I; Gherardi RK; Authier FJ; Gitiaux C
    Rheumatology (Oxford); 2018 May; 57(5):873-879. PubMed ID: 29474663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children.
    Wang X; Ding Y; Zhou Z; Hou J; Xu Y; Li J
    Pediatr Rheumatol Online J; 2021 Jan; 19(1):6. PubMed ID: 33407621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MDA5-associated dermatomyositis.
    Gupta R; Kumar S; Gow P; Hsien-Cheng Chang L; Yen L
    Intern Med J; 2020 Apr; 50(4):484-487. PubMed ID: 32270621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.
    Xu Y; Ma X; Zhou Z; Li J; Hou J; Zhu J; Kang M; Lai J; Li X
    Pediatr Rheumatol Online J; 2021 Jan; 19(1):2. PubMed ID: 33407602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermatomyositis-specific antibodies].
    Bodoki L; Nagy-Vincze M; Griger Z; Dankó K
    Z Rheumatol; 2015 May; 74(4):363-9. PubMed ID: 25644067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dermatomyositis: new antibody, new classification].
    Bolko L; Gitiaux C; Allenbach Y
    Med Sci (Paris); 2019 Nov; 35 Hors série n° 2():18-23. PubMed ID: 31859626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.